{"altmetric_id":3998350,"counts":{"readers":{"citeulike":"0","mendeley":"8","connotea":"0"},"total":{"posts_count":10},"twitter":{"unique_users_count":6,"unique_users":["EduEyras","MPAlonso","ClinChemINFO","AScancer_papers","leviaingenia","endre_sebestyen"],"posts_count":8},"weibo":{"unique_users_count":2,"unique_users":["瑞sun","来邦网"],"posts_count":2},"downloads":{"publisher":{"views_granted_access":1321,"timeline":{"2015-05-18":58,"2015-05-19":38,"2015-05-20":44,"2015-05-21":27,"2015-05-22":15,"2015-05-24":2,"2015-05-25":10,"2015-05-26":8,"2015-05-27":7,"2015-05-28":9,"2015-05-29":13,"2015-05-30":2,"2015-05-31":5,"2015-06-03":7,"2015-06-04":12,"2015-06-05":10,"2015-06-06":2,"2015-06-07":2,"2015-06-08":11,"2015-06-09":6,"2015-06-10":1,"2015-06-11":9,"2015-06-12":4,"2015-06-13":1,"2015-06-14":5,"2015-06-15":8,"2015-06-16":12,"2015-06-18":3,"2015-06-19":2,"2015-06-20":3,"2015-06-22":7,"2015-06-23":6,"2015-06-24":1,"2015-06-25":9,"2015-06-26":4,"2015-06-27":1,"2015-06-30":6,"2015-07-01":1,"2015-07-02":3,"2015-07-03":3,"2015-07-05":4,"2015-07-06":1,"2015-07-08":8,"2015-07-09":3,"2015-07-10":12,"2015-07-13":6,"2015-07-14":3,"2015-07-15":1,"2015-07-16":2,"2015-07-17":3,"2015-07-19":1,"2015-07-20":1,"2015-07-21":2,"2015-07-22":5,"2015-07-26":2,"2015-07-27":4,"2015-07-28":1,"2015-07-29":1,"2015-07-30":4,"2015-08-04":3,"2015-08-05":7,"2015-08-06":2,"2015-08-09":1,"2015-08-10":4,"2015-08-11":7,"2015-08-12":4,"2015-08-14":1,"2015-08-16":1,"2015-08-17":1,"2015-08-18":5,"2015-08-19":2,"2015-08-20":6,"2015-08-21":4,"2015-08-24":6,"2015-08-25":4,"2015-08-26":3,"2015-08-28":1,"2015-08-29":2,"2015-08-31":4,"2015-09-01":2,"2015-09-02":3,"2015-09-03":2,"2015-09-04":4,"2015-09-05":1,"2015-09-06":1,"2015-09-07":1,"2015-09-08":2,"2015-09-09":2,"2015-09-10":6,"2015-09-14":1,"2015-09-15":3,"2015-09-16":4,"2015-09-17":4,"2015-09-18":1,"2015-09-20":5,"2015-09-21":1,"2015-09-24":2,"2015-09-25":2,"2015-09-26":4,"2015-09-28":2,"2015-09-30":1,"2015-10-04":1,"2015-10-06":2,"2015-10-07":2,"2015-10-08":1,"2015-10-10":2,"2015-10-14":3,"2015-10-15":2,"2015-10-16":3,"2015-10-17":2,"2015-10-18":2,"2015-10-19":2,"2015-10-20":7,"2015-10-21":5,"2015-10-23":3,"2015-10-24":3,"2015-10-25":2,"2015-10-26":2,"2015-10-27":3,"2015-10-28":1,"2015-10-29":2,"2015-10-30":1,"2015-11-01":2,"2015-11-02":1,"2015-11-03":2,"2015-11-04":4,"2015-11-05":1,"2015-11-06":1,"2015-11-08":8,"2015-11-09":1,"2015-11-11":4,"2015-11-12":1,"2015-11-13":1,"2015-11-14":3,"2015-11-16":2,"2015-11-17":10,"2015-11-18":2,"2015-11-19":2,"2015-11-20":2,"2015-11-24":1,"2015-11-25":4,"2015-11-26":4,"2015-11-27":2,"2015-11-30":1,"2015-12-01":2,"2015-12-04":2,"2015-12-08":1,"2015-12-09":3,"2015-12-10":2,"2015-12-11":1,"2015-12-12":1,"2015-12-16":2,"2015-12-18":2,"2015-12-22":2,"2015-12-26":1,"2015-12-30":2,"2016-01-04":4,"2016-01-05":2,"2016-01-06":1,"2016-01-08":2,"2016-01-11":3,"2016-01-12":4,"2016-01-13":2,"2016-01-15":1,"2016-01-16":2,"2016-01-17":1,"2016-01-18":2,"2016-01-19":7,"2016-01-22":4,"2016-01-23":1,"2016-01-25":1,"2016-01-26":3,"2016-01-27":2,"2016-01-28":5,"2016-01-29":2,"2016-01-30":2,"2016-02-01":1,"2016-02-02":2,"2016-02-04":6,"2016-02-05":5,"2016-02-07":1,"2016-02-08":3,"2016-02-09":5,"2016-02-10":1,"2016-02-14":2,"2016-02-15":3,"2016-02-16":5,"2016-02-17":1,"2016-02-18":4,"2016-02-19":2,"2016-02-22":4,"2016-02-23":5,"2016-02-24":1,"2016-02-25":6,"2016-02-26":4,"2016-02-27":3,"2016-02-29":3,"2016-03-02":1,"2016-03-03":6,"2016-03-04":3,"2016-03-06":2,"2016-03-07":2,"2016-03-08":4,"2016-03-09":10,"2016-03-10":7,"2016-03-11":10,"2016-03-12":1,"2016-03-13":6,"2016-03-14":11,"2016-03-15":1,"2016-03-16":2,"2016-03-17":6,"2016-03-20":3,"2016-03-21":10,"2016-03-22":3,"2016-03-23":2,"2016-03-24":2,"2016-03-25":1,"2016-03-26":4,"2016-03-28":2,"2016-03-30":6,"2016-03-31":4,"2016-04-01":2,"2016-04-02":1,"2016-04-03":3,"2016-04-04":3,"2016-04-05":5,"2016-04-06":5,"2016-04-07":9,"2016-04-08":2,"2016-04-09":1,"2016-04-11":1,"2016-04-12":6,"2016-04-14":2,"2016-04-15":2,"2016-04-16":1,"2016-04-17":1,"2016-04-18":5,"2016-04-19":6,"2016-04-21":6,"2016-04-22":1,"2016-04-25":6,"2016-04-26":1,"2016-04-27":8,"2016-04-28":7,"2016-04-29":5,"2016-04-30":4,"2016-05-02":6,"2016-05-03":5,"2016-05-04":10,"2016-05-05":1,"2016-05-06":7,"2016-05-08":5,"2016-05-09":3,"2016-05-10":8,"2016-05-11":18,"2016-05-12":2,"2016-05-13":3,"2016-05-14":3,"2016-05-15":1,"2016-05-16":5,"2016-05-17":2,"2016-05-18":2,"2016-05-19":8,"2016-05-20":9,"2016-05-21":2,"2016-05-22":4,"2016-05-23":2,"2016-05-24":2,"2016-05-25":1,"2016-05-26":6,"2016-05-27":2,"2016-05-28":2,"2016-05-29":5,"2016-05-30":3,"2016-05-31":4,"2016-06-01":2,"2016-06-02":13,"2016-06-06":9,"2016-06-07":6,"2016-06-08":2,"2016-06-09":1,"2016-06-10":3,"2016-06-12":1,"2016-06-13":1,"2016-06-14":3,"2016-06-15":3,"2016-06-16":4,"2016-06-17":1,"2016-06-18":2,"2016-06-20":6,"2016-06-22":1,"2016-06-24":2,"2016-06-26":1,"2016-06-27":3,"2016-06-28":8,"2016-06-29":9,"2016-06-30":1,"2016-07-01":1,"2016-07-03":3,"2016-07-04":7,"2016-07-07":7,"2016-07-08":2,"2016-07-09":3,"2016-07-11":8,"2016-07-12":6,"2016-07-13":6,"2016-07-14":4,"2016-07-15":2,"2016-07-16":1,"2016-07-18":7,"2016-07-19":7,"2016-07-20":4,"2016-07-21":2,"2016-07-25":1,"2016-07-26":4,"2016-07-27":2,"2016-07-29":2,"2016-07-30":2,"2016-07-31":1,"2016-08-01":1,"2016-08-02":1,"2016-08-03":5,"2016-08-04":2,"2016-08-05":3}}}},"selected_quotes":["A branch point mutation produces anti-BRAF resistant cells"],"citation":{"abstract":"Mutations in the serine/threonine kinase BRAF are found in more than 60% of melanomas. The most prevalent melanoma mutation is BRAF(V600E), which constitutively activates downstream MAPK signalling. Vemurafenib is a potent RAF kinase inhibitor with remarkable clinical activity in BRAF(V600E)-positive melanoma tumours. However, patients rapidly develop resistance to vemurafenib treatment. One resistance mechanism is the emergence of BRAF alternative splicing isoforms leading to elimination of the RAS-binding domain. Here we identify interference with pre-mRNA splicing as a mechanism to combat vemurafenib resistance. We find that small-molecule pre-mRNA splicing modulators reduce BRAF3-9 production and limit in-vitro cell growth of vemurafenib-resistant cells. In xenograft models, interference with pre-mRNA splicing prevents tumour formation and slows growth of vemurafenib-resistant tumours. Our results identify an intronic mutation as the molecular basis for a RNA splicing-mediated RAF inhibitor resistance mechanism and we identify pre-mRNA splicing interference as a potential therapeutic strategy for drug resistance in BRAF melanoma.","altmetric_jid":"4f6fa62f3cf058f610008259","authors":["Maayan Salton","Wojciech K. Kasprzak","Ty Voss","Bruce A. Shapiro","Poulikos I. Poulikakos","Tom Misteli","Salton, Maayan","Kasprzak, Wojciech K","Voss, Ty","Shapiro, Bruce A","Poulikakos, Poulikos I","Misteli, Tom"],"doi":"10.1038/ncomms8103","first_seen_on":"2015-05-15T06:07:42+00:00","funders":["niehs","phs"],"issns":["2041-1723"],"journal":"Nature Communications","links":["http://www.nature.com/ncomms/2015/150514/ncomms8103/full/ncomms8103.html","http://www.ncbi.nlm.nih.gov/pubmed/25971842?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","https://www.ncbi.nlm.nih.gov/pubmed/25971842"],"pmid":"25971842","pubdate":"2015-05-14T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Multidisciplinary","scheme":"era"}],"subjects":["biology","science"],"title":"Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.","type":"article","volume":"6","mendeley_url":"http://www.mendeley.com/research/interference-premrna-splicing"},"altmetric_score":{"score":4.45,"score_history":{"1y":0.5,"6m":0.5,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.45},"context_for_score":{"all":{"total_number_of_other_articles":5285382,"mean":6.2167114007507,"rank":1083873,"this_scored_higher_than_pct":79,"this_scored_higher_than":4196338,"rank_type":"exact","sample_size":5285382,"percentile":79},"similar_age_3m":{"total_number_of_other_articles":166999,"mean":9.3254804847964,"rank":45538,"this_scored_higher_than_pct":72,"this_scored_higher_than":121138,"rank_type":"exact","sample_size":166999,"percentile":72},"this_journal":{"total_number_of_other_articles":8743,"mean":34.971526195379,"rank":5120,"this_scored_higher_than_pct":41,"this_scored_higher_than":3609,"rank_type":"exact","sample_size":8743,"percentile":41},"similar_age_this_journal_3m":{"total_number_of_other_articles":700,"mean":29.446460658083,"rank":397,"this_scored_higher_than_pct":43,"this_scored_higher_than":302,"rank_type":"exact","sample_size":700,"percentile":43}}},"demographics":{"poster_types":{"member_of_the_public":4,"researcher":2},"users":{"twitter":{"cohorts":{"Scientists":2,"Members of the public":4}},"mendeley":{"by_status":{"Researcher":2,"Student  > Master":2,"Professor":1,"Student  > Ph. D. Student":3},"by_discipline":{"Engineering":1,"Physics and Astronomy":1,"Agricultural and Biological Sciences":6}}},"geo":{"twitter":{"ES":2,"IT":1},"mendeley":{"CA":1}}},"posts":{"twitter":[{"url":"https://twitter.com/EduEyras/status/600246624301019136","posted_on":"2015-05-18T10:28:41+00:00","license":"datasift","rt":["AScancer_papers"],"citation_ids":[3998350],"author":{"name":"Eduardo Eyras","url":"http://regulatorygenomics.upf.edu","image":"https://pbs.twimg.com/profile_images/652924706442625024/GjzmoEGk_normal.jpg","description":"Recycled theoretical physicist working on computational biology of RNA and cancer. ICREA & UPF","id_on_source":"EduEyras","tweeter_id":"453495437","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":986},"tweet_id":"600246624301019136"},{"url":"https://twitter.com/EduEyras/status/600247169233395712","posted_on":"2015-05-18T10:30:51+00:00","license":"datasift","citation_ids":[3998350],"author":{"name":"Eduardo Eyras","url":"http://regulatorygenomics.upf.edu","image":"https://pbs.twimg.com/profile_images/652924706442625024/GjzmoEGk_normal.jpg","description":"Recycled theoretical physicist working on computational biology of RNA and cancer. ICREA & UPF","id_on_source":"EduEyras","tweeter_id":"453495437","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":986},"tweet_id":"600247169233395712"},{"url":"https://twitter.com/MPAlonso/status/600247916033376257","posted_on":"2015-05-18T10:33:49+00:00","license":"datasift","rt":["EduEyras"],"citation_ids":[3998350],"author":{"name":"Manuel Pérez-Alonso","url":"http://www.linkedin.com/in/manuelperezalonso","image":"https://pbs.twimg.com/profile_images/676542722350690305/XuYV-_Yo_normal.jpg","description":"Profesor universitario, investigador y emprendedor | Director del Instituto de Medicina Genómica @ImegenTw | Aquí sólo mis opiniones","id_on_source":"MPAlonso","tweeter_id":"60956542","geo":{"lt":null,"ln":null},"followers":17371},"tweet_id":"600247916033376257"},{"url":"https://twitter.com/ClinChemINFO/status/600277114915561472","posted_on":"2015-05-18T12:29:51+00:00","license":"datasift","rt":["EduEyras"],"citation_ids":[3998350],"author":{"name":"ClinChemINFO","url":"http://www.clinicalchemistry.info","image":"https://pbs.twimg.com/profile_images/556141595234275329/392ECMgd_normal.png","id_on_source":"ClinChemINFO","tweeter_id":"2981358863","geo":{"lt":null,"ln":null},"followers":367},"tweet_id":"600277114915561472"},{"url":"https://twitter.com/AScancer_papers/status/599157038342479872","posted_on":"2015-05-15T10:19:04+00:00","license":"datasift","citation_ids":[3998350],"author":{"name":"AScancer_papers","image":"https://pbs.twimg.com/profile_images/516232958110212098/KO1xV-0U_normal.jpeg","description":"Bot of alternative splicing and cancer papers in @NCBI #PubMed. Curated by @endre_sebestyen.","id_on_source":"AScancer_papers","tweeter_id":"2789066381","geo":{"lt":null,"ln":null},"followers":66},"tweet_id":"599157038342479872"},{"url":"https://twitter.com/leviaingenia/status/600966386089857024","posted_on":"2015-05-20T10:08:46+00:00","license":"datasift","citation_ids":[3998350],"author":{"name":"José Lozano","url":"https://medium.com/@leviaingenia","image":"https://pbs.twimg.com/profile_images/720017594573570049/2owouogH_normal.jpg","description":"Biólogo Molecular, Profesor Titular. Molecular Biologist, Associate Professor @infoUMA. Do the best experiments you can and always tell the truth” (S. Brenner)","id_on_source":"leviaingenia","tweeter_id":"2867775657","geo":{"lt":36.72016,"ln":-4.42034,"country":"ES"},"followers":425},"tweet_id":"600966386089857024"},{"url":"https://twitter.com/endre_sebestyen/status/600654998394011648","posted_on":"2015-05-19T13:31:25+00:00","license":"datasift","rt":["AScancer_papers"],"citation_ids":[3998350],"author":{"name":"Endre Sebestyén","image":"https://pbs.twimg.com/profile_images/505073126451847168/vUVmCPWI_normal.jpeg","description":"Cancer is my model animal.","id_on_source":"endre_sebestyen","tweeter_id":"2770242926","geo":{"lt":45.46427,"ln":9.18951,"country":"IT"},"followers":174},"tweet_id":"600654998394011648"},{"url":"http://twitter.com/AScancer_papers/statuses/714712329347338241","posted_on":"2016-03-29T07:14:32+00:00","license":"gnip","citation_ids":[3998350],"author":{"name":"AScancer_papers","image":"https://pbs.twimg.com/profile_images/516232958110212098/KO1xV-0U_normal.jpeg","description":"Bot of alternative splicing and cancer papers in @NCBI #PubMed. Curated by @endre_sebestyen.","id_on_source":"AScancer_papers","tweeter_id":"2789066381","geo":{"lt":null,"ln":null},"followers":66},"tweet_id":"714712329347338241"}],"weibo":[{"url":"http://weibo.com/1651747371/CiuQMoPHI","posted_on":"2015-05-18T21:32:18+00:00","license":"public","citation_ids":[3998350],"author":{"name":"瑞sun","image":"http://tp4.sinaimg.cn/1651747371/50/5683038442/1","id_on_source":"1651747371","followers":38}},{"url":"http://weibo.com/2238278172/Cinl6rOr1","posted_on":"2015-05-18T02:25:02+00:00","license":"public","citation_ids":[3998350],"author":{"name":"来邦网","url":"http://www.labome.com/","image":"http://tp1.sinaimg.cn/2238278172/50/5605269192/1","description":"了解生命, 了解科研, 了解创业","id_on_source":"2238278172","followers":15069}}]},"score":4.45,"images":{"small":"https://altmetric-badges.a.ssl.fastly.net/?size=64&score=5&types=sstttttt","medium":"https://altmetric-badges.a.ssl.fastly.net/?size=100&score=5&types=sstttttt","large":"https://altmetric-badges.a.ssl.fastly.net/?size=180&score=5&types=sstttttt"}}